{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:32:59Z","timestamp":1760783579886,"version":"3.40.3"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.jpba.2012.07.023","type":"journal-article","created":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T21:02:13Z","timestamp":1344546133000},"page":"157-161","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["A 96-well filtration method for radioligand binding analysis of \u03c3 receptor ligands"],"prefix":"10.1016","volume":"71","author":[{"given":"James A.","family":"Fishback","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abagail","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher R.","family":"McCurdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rae R.","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2012.07.023_bib0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0006-8993(92)90340-F","article-title":"Autoradiographic distribution of [3H](+)-Pentazocine and [3H]1,3-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative study","volume":"581","author":"Walker","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.jpba.2012.07.023_bib0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0165-6147(92)90030-A","article-title":"A proposal for the classification of sigma binding sites","volume":"13","author":"Quirion","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jpba.2012.07.023_bib0015","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2174\/157015908787386113","article-title":"Pharmacology and therapeutic potential of sigma1 receptor ligands","volume":"6","author":"Cobos","year":"2008","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jpba.2012.07.023_bib0020","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.2174\/138161206778559614","article-title":"Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals","volume":"12","author":"Hashimoto","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jpba.2012.07.023_bib0025","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/1871524910909030230","article-title":"Development of molecular probes for imaging sigma-2 receptors in vitro and in vivo","volume":"9","author":"Mach","year":"2009","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.jpba.2012.07.023_bib0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharmthera.2009.07.001","article-title":"The pharmacology of sigma-1 receptors","volume":"124","author":"Maurice","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2012.07.023_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroimage.2006.11.055","article-title":"Mapping of human cerebral sigma1 receptors using positron emission tomography and [11C]SA4503","volume":"35","author":"Sakata","year":"2007","journal-title":"Neuroimage"},{"key":"10.1016\/j.jpba.2012.07.023_bib0040","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.bmc.2008.12.025","article-title":"New N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl phenylcarbamate analogs as sigma2 receptor ligands: synthesis, in vitro characterization, and evaluation as PET imaging and chemosensitization agents","volume":"17","author":"Chu","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jpba.2012.07.023_bib0045","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bmc.2010.11.013","article-title":"Synthesis, pharmacological activity and structure affinity relationships of spirocyclic sigma1 receptor ligands with a (2-fluoroethyl) residue in 3-position","volume":"19","author":"Maestrup","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jpba.2012.07.023_bib0050","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1021\/jm8012344","article-title":"Synthesis and in vitro and in vivo evaluation of 18F-labeled positron emission tomography (PET) ligands for imaging the vesicular acetylcholine transporter","volume":"52","author":"Tu","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2012.07.023_bib0055","doi-asserted-by":"crossref","first-page":"6988","DOI":"10.1016\/j.bmc.2006.06.028","article-title":"Synthesis of N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl carbamate analogs as sigma2 receptor ligands","volume":"14","author":"Vangveravong","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jpba.2012.07.023_bib0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2005.09.063","article-title":"[3H]N-[4-(3,4-dihydro-6,7-dimethoxyisoquinolin-2(1h)-yl)butyl]-2-methoxy-5-methylbenzamide: a novel sigma-2 receptor probe","volume":"525","author":"Xu","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpba.2012.07.023_bib0065","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1073\/pnas.93.15.8072","article-title":"Purification, molecular cloning, and expression of the mammalian sigma1-binding site","volume":"93","author":"Hanner","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jpba.2012.07.023_bib0070","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/sj.bjp.0704626","article-title":"Evidence for sigma-1-like receptors in isolated rat liver mitochondrial membranes","volume":"135","author":"Klouz","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpba.2012.07.023_bib0075","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-5793(03)01011-1","article-title":"[3H]BHDP as a novel and selective ligand for sigma1 receptors in liver mitochondria and brain synaptosomes of the rat","volume":"553","author":"Klouz","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jpba.2012.07.023_bib0080","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/108705710000500410","article-title":"Development assay for of a 5-hydroxytryptamine2a receptor binding high throughput screening using 96-well microfilter plates","volume":"5","author":"Harms","year":"2000","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.jpba.2012.07.023_bib0085","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1471-4159.1995.64020677.x","article-title":"Characterization of ligand binding to the cannabinoid receptor of rat brain membranes using a novel method: application to anandamide","volume":"64","author":"Hillard","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jpba.2012.07.023_bib0090","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/1087057104271330","article-title":"Comparison of 3 AT1 receptor binding assays: filtration assay, ScreenReady Target, and WGA flashplate","volume":"10","author":"Van Der Hee","year":"2005","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.jpba.2012.07.023_bib0095","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/0006-2952(94)90395-6","article-title":"Sigma recognition sites in brain and peripheral tissues. Characterization and effects of cytochrome P450 inhibitors","volume":"47","author":"DeHaven-Hudkins","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jpba.2012.07.023_bib0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0922-4106(94)90115-5","article-title":"Rat liver and kidney contain high densities of sigma1 and sigma2 receptors: characterization by ligand binding and photoaffinity labeling","volume":"268","author":"Hellewell","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpba.2012.07.023_bib0105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0014-2999(97)01248-X","article-title":"2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives: Novel, potent and selective sigma1 receptor ligands","volume":"335","author":"Ucar","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpba.2012.07.023_bib0110","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s00044-005-0131-1","article-title":"Novel 2(3H)-benzothiazolones as highly potent and selective sigma-1 receptor ligands","volume":"14","author":"Yous","year":"2005","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.jpba.2012.07.023_bib0115","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-2999(95)00208-3","article-title":"Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism","volume":"280","author":"Matsumoto","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpba.2012.07.023_bib0120","first-page":"117","article-title":"[3H]-(+)-Pentazocine: a potent and highly selective benzomorphan-based probe for sigma-1 receptors","volume":"1","author":"Bowen","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jpba.2012.07.023_bib0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0014-2999(96)00008-8","article-title":"Dissociation of the motor effects of (+)-pentazocine from binding to sigma1 sites","volume":"301","author":"Matsumoto","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpba.2012.07.023_bib0130","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jpba.2012.07.023_bib0135","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1006\/bbrc.1996.1842","article-title":"Cloning and functional expression of the human type 1 sigma receptor (hsigmar1)","volume":"229","author":"Kekuda","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jpba.2012.07.023_bib0140","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0006-2952(01)00666-9","article-title":"Molecular cloning and pharmacological characterization of the rat sigma1 receptor","volume":"62","author":"Mei","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jpba.2012.07.023_bib0145","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1046\/j.1471-4159.1998.70062279.x","article-title":"Cloning and characterization of a mouse sigma1 receptor","volume":"70","author":"Pan","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jpba.2012.07.023_bib0150","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1046\/j.1471-4159.1998.70030922.x","article-title":"Cloning and functional characterization of a sigma receptor from rat brain","volume":"70","author":"Seth","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jpba.2012.07.023_bib0155","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1006\/bbrc.1997.7840","article-title":"Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor","volume":"241","author":"Seth","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jpba.2012.07.023_bib0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0922-4106(94)90102-3","article-title":"[3H](+)-Pentazocine binding to rat brain sigma1 receptors","volume":"266","author":"Cagnotto","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpba.2012.07.023_bib0165","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0022-3565(25)24688-2","article-title":"Solubilization and characterization of haloperidol-sensitive (+)-[3H]SKF-10,047 binding sites (sigma sites) from rat liver membranes","volume":"257","author":"McCann","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jpba.2012.07.023_bib0170","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/syn.890170307","article-title":"Sigma-1 and sigma-2 sites in rat brain: comparison of regional, ontogenetic, and subcellular patterns","volume":"17","author":"McCann","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.jpba.2012.07.023_bib0175","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2004.04.005","article-title":"Sigma-2 receptors are specifically localized to lipid rafts in rat liver membranes","volume":"493","author":"Gebreselassie","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpba.2012.07.023_bib0180","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0014-2999(96)00109-4","article-title":"Differential solubilization of rat liver sigma1 and sigma2 receptors: retention of sigma2 sites in particulate fractions","volume":"304","author":"Torrence-Campbell","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpba.2012.07.023_bib0185","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pep.2006.07.019","article-title":"Purification and characterization of the guinea pig sigma-1 receptor functionally expressed in Escherichia coli","volume":"51","author":"Ramachandran","year":"2007","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jpba.2012.07.023_bib0190","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejphar.2007.09.020","article-title":"An unambiguous assay for the cloned human sigma1 receptor reveals high affinity interactions with dopamine D4 receptor selective compounds and a distinct structure\u2013affinity relationship for butyrophenones","volume":"578","author":"Lee","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpba.2012.07.023_bib0195","article-title":"Characterization of ligand binding to the sigma1 receptor in a human tumor cell line (RPMI 8226) and establishment of a competitive receptor binding assay","author":"Brune","year":"2011","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.jpba.2012.07.023_bib0200","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jpba.2011.03.044","article-title":"Expression of sigma receptors of human urinary bladder tumor cells (RT-4 cells) and development of a competitive receptor binding assay for the determination of ligand affinity to human sigma2 receptors","volume":"55","author":"Schepmann","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2012.07.023_bib0205","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0014-2999(94)90453-7","article-title":"NE-100, a novel potent sigma ligand, preferentially binds to sigma 1 binding sites in guinea pig brain","volume":"251","author":"Chaki","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpba.2012.07.023_bib0210","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.euroneuro.2008.07.006","article-title":"Attenuation of methamphetamine-induced effects through the antagonism of sigma (\u03c3) receptors: Evidence from in vivo and in vitro studies","volume":"18","author":"Matsumoto","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpba.2012.07.023_bib0215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-2999(96)00254-3","article-title":"Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain","volume":"307","author":"Narita","year":"1996","journal-title":"Eur. J. Pharmacol."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708512004293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708512004293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T19:03:12Z","timestamp":1743966192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708512004293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":43,"alternative-id":["S0731708512004293"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2012.07.023","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}